Search
Pharmacology
A look inside Mindstate Design Labs' effort to design drugs that reliably produce specific states of mind.
Retatrutide, Eli Lilly's innovative "triple g" drug, is setting new standards in the fight against obesity.
New research shows psychedelics activate receptors inside brain cells that other compounds, like serotonin, cannot.
Hundreds of these cannabis-related chemicals now exist, both natural and synthetic, inspiring researchers in search of medical breakthroughs.
The placebo effect is real. So are the ethical conundrums posed by those who would exploit the latest research advances for profit.
The cannabis plant produces both THC – the psychoactive component in marijuana – and the compound commonly known as CBD, which does not lead to a "high."
Antidepressants can help alleviate PTSD symptoms when paired with psychotherapy, but does our overenthusiasm for them blind us to more effective alternatives?
The serotonin theory of depression started to be widely promoted in the 1990s, coinciding with a push to prescribe more SSRIs.
Noradrenaline-targeting drugs, including blood pressure, depression, and ADHD meds, improve Alzheimer's disease symptoms.
Drugs that stifle acute inflammation may prevent the body from healing properly.
Thanks to genetic clues, scientists discovered that an old stroke therapy that had abandoned for decades might just work.
Disulfiram is an FDA-approved drug for the treatment of chronic alcoholism. It might also serve as anti-anxiety medication.
Zuranolone might help people feel better sooner than if they were relying on standard treatment alone.